Kcsn.org.uk / Support Groups
Domain overview in Support Groups niche. Based on relevant links and pages only.
| kcsn.org.uk rank 9185 |
| Number of domains linked from kcsn.org.uk 25 | semantic flow 0.89 |
| Number of links from kcsn.org.uk 33 | semantic flow 0.89 |
Popular pages pointing to kcsn.org.uk
Pages with highest topical PageRank pointing to domain.
Popular pages from kcsn.org.uk
On-topic pages from domain with highest topical PageRank.
| title / url |  | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|
| Clinical Trial Resources - Kidney Cancer Support Network http://www.kcsn.org.uk/clinical-trials-hub/clinical-trial-resources/  | 0.28 | 1 | 52 | 33 | 1 | 1 | 0 | 0 | |
| Real world data - Kidney Cancer Support Network http://www.kcsn.org.uk/glossary/real-world-data/ | 0.28 | 0.99 | 55 | 33 | 1 | 1 | 0 | 0 | |
| Cabozantinib - Kidney Cancer Support Network http://www.kcsn.org.uk/glossary/cabozantinib-cometriq/ | 0.21 | 0.99 | 64 | 36 | 1 | 1 | 0 | 0 | |
| easyfundraising.org.uk - Kidney Cancer Support Network http://www.kcsn.org.uk/easyfundraising-org-uk/ | 0.21 | 0.97 | 53 | 32 | 1 | 1 | 0 | 0 | |
| Glossary of Terma used in Clinical Trials - Kidney Cancer Support Network http://www.kcsn.org.uk/forums/topic/glossary-of-terma-used-in-clinical-trials/ | 0.19 | 1 | 56 | 34 | 1 | 1 | 0 | 0 |
Domains with most semantic flow from kcsn.org.uk
Relevant domains with most links from selected domain.
Most linked pages from kcsn.org.uk
Pages from domain with most relevant inbound links.
| url | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| http://www.kcsn.org.uk/clinical-trials-hub/ | 2 | 0.15 | 0.85 | 0.09 | 0.99 | yes | 58 | 37 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/ | 1 | 0.15 | 0.96 | 0.08 | 0.88 | yes | 94 | 52 | 2 | 2 | 1 | 1 | |
| http://www.kcsn.org.uk/community/patient-stories/ | 1 | 0.15 | 0.96 | 0.05 | 1 | yes | 51 | 32 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/clinical-trials-hub/patient-stories/ | 1 | 0.15 | 0.96 | 0.05 | 1 | yes | 51 | 32 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/community/patient-database/ | 1 | 0.15 | 0.96 | 0.05 | 0.98 | yes | 65 | 42 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/support-us/corporate-support-and-grants/ | 1 | 0.15 | 0.96 | 0.05 | 1 | yes | 55 | 34 | 1 | 1 | 0 | 0 | |
| http://kcsn.org.uk/community/ | 1 | 0.15 | 0.85 | 0.05 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
| http://www.kcsn.org.uk/news-room/news/ | 1 | 0.15 | 0.95 | 0.05 | 0.94 | yes | 133 | 44 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/community/link-to-facebook-page/ | 1 | 0.15 | 0.62 | 0.03 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 | |
| http://kcsn.org.uk/clinical-trials-hub/patient-stories/ | 1 | 0.15 | 0.81 | 0.03 | -1 | - | -1 | -1 | -1 | -1 | 0 | 0 |
Hubs from kcsn.org.uk
Pages from domain with most likely on-topic outgoing links.
| url | | | | | | | | | | | | | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| http://www.kcsn.org.uk/ | 52 | 0.15 | 0.96 | 2.55 | 0.88 | yes | 94 | 52 | 2 | 2 | 1 | 1 | |
| http://www.kcsn.org.uk/combination-immunotherapy-new-standard-care-metastatic-kidney-cance | 9 | 0.15 | 0.95 | 0.58 | 0.99 | yes | 74 | 45 | 3 | 3 | 0 | 0 | |
| http://www.kcsn.org.uk/clinical-trials-hub/ | 3 | 0.15 | 0.85 | 0.17 | 0.99 | yes | 58 | 37 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/support-us/ | 2 | 0.15 | 0.96 | 0.13 | 1 | yes | 59 | 36 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/news-room/news/ | 2 | 0.15 | 0.95 | 0.12 | 0.94 | yes | 133 | 44 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/get-involved/ | 2 | 0.15 | 0.95 | 0.12 | 1 | yes | 61 | 35 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/community/patient-database/ | 2 | 0.15 | 0.96 | 0.12 | 0.98 | yes | 65 | 42 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/about-us/medical-advisory-board/ | 2 | 0.15 | 0.96 | 0.12 | 0.99 | yes | 55 | 37 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/clinical-trials-hub/patient-stories/ | 1 | 0.15 | 0.96 | 0.07 | 1 | yes | 51 | 32 | 1 | 1 | 0 | 0 | |
| http://www.kcsn.org.uk/support-us/corporate-support-and-grants/ | 1 | 0.15 | 0.96 | 0.07 | 1 | yes | 55 | 34 | 1 | 1 | 0 | 0 |